
News from Optimum Strategic Communications
Top Optimum Strategic Communications News

VaccinesLeverages Kling's technology to discover hard-to-find, immuno-functional antibodies from immortalized human B cellsAccelerating discovery of first-in-class antibodies to transform disease prevention and treatmentSee the Story
Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies
100% Center coverage: 2 sources

European UnionFunding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology platform, to guide treatment decisions, patient selection, therapy development, and optimize clinical trialsProceeds will also help scale strategic partnerships…See the Story